Cell line development (CLD) is a vital component of biopharmaceutical development, focused on generating stable and high-quality cell lines for the production of therapeutic proteins. This process ...

Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues ...

Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the launch of Cyto-Cellect® Fc Fusion, a novel assay designed to ...

Our systems make the development of new biopharmaceuticals faster and more cost-effective, improve monoclonal antibody screening, cell line development, and overall research efficiency in a number ...

This webinar will be hosted live and available on-demand Tuesday, September 24, 2024 2:30 PM Eastern Time Luciferase-based reporter cell lines are invaluable for detecting cellular responses to ...

In this GEN webinar, Thibault Laurent, an expert in cell line development and genome engineering, shares a data-driven vision for the future of biologics production and discusses progress toward ...

Successful commercialization of a biopharmaceutical product is dependent upon an effective, high-quality cell-line development process. While high-throughput analytical instruments often take center ...

Biopharmaceutical manufacturing of proteins requires an efficient cell line. Starting with several thousand clones, researchers use multiple selection rounds to ultimately chose one clone for the ...

CAMBRIDGE, England--(BUSINESS WIRE)--Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the launch of Cyto ...